Affiliate Event
Speakers: Dr. Husam Abdel-Qadir (Cardiologist, Women’s College Hospital / UHN) & Dr. Abi Vijenthira (Hematologist, Princess Margaret Cancer Centre)
Learning Objectives:
- Describe the role of BTK inhibitors in the current treatment landscape for haematological malignancies;
- Understand the cardiovascular risks associated with first and newer generation BTK inhibitors
- Better understand the risk-benefit balance of using BTK inhibitors in patients with cardiovascular disease or at increased risk for it
Audience:
Clinicians, Fellows, Trainees
Registration:
Please register prior to the event. A link to Zoom will follow in a separate email prior to the webinar.
Accreditation:
This webinar is unaccredited.
Disclaimer:
The CCS reserves the right to use any photo or video image recorded at the CCON Webinar. By registering for the event, you hereby acknowledge and agree that CCS may photograph and/or videotape you at this event, as well as use the photographs and/or videotapes in any publication or media for future educational and promotional activities/materials, without further notification or any compensation to you.